Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-21-012546

Director sold 6,000 shares at an average $52.40 ($314,383)

  • Director acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kurkijarvi Kalevi · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-17 Exercise or conversion : show line 1 in the form +6,000 $28.65 $171,900 39,100 D
2021-02-17 Sale : show line 2 in the form −5,156 $52.31 $269,710 33,944 D
2021-02-17 Sale : show line 3 in the form −844 $52.93 $44,673 33,100 D
Open-market sales · 6,000 sh · avg $52.40 · $314,383

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-17 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −6,000 $28.65 2027-06-07 6,000 6,000 D
Loading xslF345X03/doc4.xml…